Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: Confirmation in an independent sample and meta-analysis

Addiction Biology

Volumn 18, Issue 4, 2013, Pages 702-708

  Clarke, Toni Kim ^a   Bloch, Paul J ^a   Ambrose Lanci, Lisa M ^a   Ferraro, Thomas N ^a   Berrettini, Wade H ^a   Kampman, Kyle M ^a   Dackis, Charles A ^a   Pettinati, Helen M ^a   O'Brien, Charles P ^a   Oslin, David W ^a,b   Lohoff, Falk W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Addiction; association study; cannabinoid receptor; CNRI; cocaine; genetics

Indexed keywords

ANTIDEPRESSANT AGENT; CANNABINOID RECEPTOR; COCAINE; ENDOCANNABINOID; PSYCHOTROPIC AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD SAMPLING; COCAINE DEPENDENCE; COMORBIDITY; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DOPAMINERGIC ACTIVITY; ETHNICITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOME; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; NEUROBIOLOGY; PRIORITY JOURNAL; PSYCHOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SUICIDAL IDEATION;

ADOLESCENT; AFRICAN AMERICANS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COCAINE; COCAINE-RELATED DISORDERS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOPAMINE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, CANNABINOID, CB1; REWARD; UNITED STATES;

EID: 84879464553     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2011.00346.x     Document Type: Article

References (46)

1. Agrawal A, Wetherill L, Dick DM, Xuei X, Hinrichs A, Hesselbrock V, Kramer J, Nurnberger JI, Schuckit M, Bierut LJ, Edenberg HJ, Foroud T, (2009) Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence. Am J Med Genet B Neuropsychiatr Genet 150B: 736-740.
2. Ameri A, (1999) The effects of cannabinoids on the brain. Prog Neurobiol 58: 315-348. (Pubitemid 29230000)
3. Balding DJ, (2006) A tutorial on statistical methods for population association studies. Nat Rev Genet 7: 781-791. (Pubitemid 44413222)
4. Ballon N, Leroy S, Bourdel MC, Charles-Nicolas A, Krebs MO, Poirier MF, (2006) (AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population. Pharmacogenomics 6: 126.
5. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I, (2001) Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125: 279-284. (Pubitemid 33000466)
6. Benyamina A, Kebir O, Blecha L, Reynaud M, Krebs M-O, (2010) CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis. Addict Biol 16: 1-6. Epub ahead of print.
7. Berrettini WH, Persico AM, (1996) Dopamine D2 receptor gene polymorphisms and vulnerability to substance abuse in African Americans. Biol Psychiatry 40: 144-147. (Pubitemid 26202445)
8. Centonze D, Battista N, Rossi S, Mercuri NB, Finazzi-Agro A, Bernardi G, Calabresi P, Maccarrone M, (2004) A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal GABAergic transmission. Neuropsychopharmacology 29: 1488-1497. (Pubitemid 38982241)
9. Cheer JF, Wassum KM, Sombers LA, Heien ML, Ariansen JL, Aragona BJ, Phillips PE, Wightman RM, (2007a) Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J Neurosci 27: 791-795. (Pubitemid 46174497)
10. Cheer JF, Wassum KM, Sombers LA, Heien MLAV, Ariansen JL, Aragona BJ, Phillips PEM, Wightman RM, (2007b) Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J Neurosci 27: 791-795. (Pubitemid 46174497)
11. Corbillé AG, Valjent E, Marsicano G, Ledent C, Lutz B, Hervé D, Girault JA, (2007) Role of cannabinoid type 1 receptors in locomotor activity and striatal signaling in response to psychostimulants. J Neurosci 27: 6937-6947. (Pubitemid 47015899)
12. Cossu G, Ledent C, Fattore L, Imperato A, Bohme GA, Parmentier M, Fratta W, (2001) Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav Brain Res 118: 61-65. (Pubitemid 32037114)
13. Covault J, Gelernter J, Kranzler H, (2001) Association study of cannabinoid receptor gene (CNR1) alleles and drug dependence. Mol Psychiatry 6: 501-502. (Pubitemid 32772558)
14. Dackis C, O'Brien C, (2005) Neurobiology of addiction: treatment and public policy ramifications. Nat Neurosci 8: 1431-1436. (Pubitemid 41573650)
15. De Vries TJ, Shaham Y, Homberg JR, Crombag H, Schuurman K, Dieben J, Vanderschuren LJMJ, Schoffelmeer ANM, (2001) A cannabinoid mechanism in relapse to cocaine seeking. Nat Med 7: 1151-1154. (Pubitemid 33010025)
16. Di Chiara G, Bassareo V, Fenu S, De Luca MA, Spina L, Cadoni C, Acquas E, Carboni E, Valentini V, Lecca D, (2004) Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47: 227-241. (Pubitemid 39298267)
17. Filip M, Gołda A, Zaniewska M, McCreary AC, Nowak E, Kolasiewicz W, Przegaliński E, (2006) Involvement of cannabinoid CB1 receptors in drug addiction: effects of rimonabant on behavioral responses induced by cocaine. Pharmacol Rep 58: 806-819. (Pubitemid 46117732)
18. Freedman ML, Reich D, Penney KL, McDonald GJ, Mignault AA, Patterson N, Gabriel SB, Topol EJ, Smoller JW, Pato CN, Pato MT, Petryshen TYL, Kolonel LN, Lander ES, Sklar P, Henderson B, Hirschhorn JN, Altshuler D, (2004) Assessing the impact of population stratification on genetic association studies. Nat Genet 36: 388-393. (Pubitemid 38437262)
19. Heller D, Schneider U, Seifert J, Cimander KF, Stuhrmann M, (2001) The cannabinoid receptor gene (CNR1) is not affected in German i.v. drug users. Addict Biol 6: 183-187. (Pubitemid 32436734)
20. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, Decosta BR, Rice KC, (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87: 1932-1936.
21. Herman AI, Kranzler HR, Cubells JF, Gelernter J, Covault J, (2006) Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence. Am J Med Genet B Neuropsychiatr Genet 141B: 499-503. (Pubitemid 44024444)
22. Hungund BL, Szakall I, Adam A, Basavarajappa BS, Vadasz C, (2003) Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens. J Neurochem 84: 698-704. (Pubitemid 36176928)
23. Hyman SE, Malenka RC, Nestler EJ, (2006) Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29: 565-598. (Pubitemid 44476856)
24. Kendler KS, Karkowski LM, Neale MC, Prescott CA, (2000) Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch Gen Psychiatry 57: 261-269. (Pubitemid 30140435)
25. Kendler KS, Prescott CA, (1998) Cocaine use, abuse and dependence in a population-based sample of female twins. Br J Psychiatry 173: 345-350. (Pubitemid 28454823)
26. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D, (2002) The human genome browser at UCSC. Genome Res 12: 996-1006. (Pubitemid 34662293)
27. Kosoy R, Nassir R, Tian C, White PA, Butler LM, Silva G, Kittles R, Alarcon-Riquelme ME, Gregersen PK, Belmont JW, De La Vega FM, Seldin ME, (2009) Ancestry informative marker sets for determining continental origin and admixture proportion in common population in America. Human Mutation 30: 69-78.
28. Li T, Liu X, Zhu ZH, Zhao J, Hu X, Ball DM, Sham PC, Collier DA, (2000) No association between (AAT)(n) repeats in the cannabinoid receptor gene (CNR1) and heroin abuse in a Chinese population. Mol Psychiatry 5: 128-130. (Pubitemid 30229425)
29. Manzanares J, Corchero J, Romero J, Fernandez-Ruiz JJ, Ramos JA, Fuentes JA, (1999) Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol Sci 20: 287-294. (Pubitemid 29301682)
30. NSDHU Substance Abuse and Mental Health Services Administration (2003) Results from the 2002 National Survey on Drug Use and Health: National Findings. Research Triangle Park, NC: Office of Applied Studies, NHSDA Series H-22 DHHS Publication No. SMA 03-3836.
31. O'Brien MS, Anthony JC, (2005) Risk of becoming cocaine dependent: epidemiological estimates for the United States, 2000-2001 (vol 30, pg 1005, 2005). Neuropsychopharmacology 30: 1588-1588.
32. Parra EJ, Kittles RA, Argyropoulos G, Pfaff CL, Hiester K, Bonilla C, Sylvester N, Parrish-Gause D, Garvey WT, Jin L, McKeigue PM, Kamboh MI, Ferrell RE, Pollitzer WS, Shriver MD, (2001) Ancestral proportions and admixture dynamics in geographically defined African Americans living in South Carolina. Am J Phys Anthropol 114: 18-29. (Pubitemid 32047315)
33. Pfaff CL, Barnholtz-Sloan J, Wagner JK, Long JC, (2004) Information on ancestry from genetic markers. Genet Epidemiol 26: 305-315. (Pubitemid 38580382)
34. Preuss UW, Koller G, Zill P, Bondy B, Soyka M, (2003) Alcoholism-related phenotypes and genetic variants of the CB1 receptor. Eur Arch Psychiatry Clin Neurosci 253: 275-280. (Pubitemid 38075967)
35. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC, (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575. (Pubitemid 47330214)
36. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK, (1990) Comorbidity of mental-disorders with alcohol and other drug-abuse-results from the Epidemiologic Catchment-Area (Eca) study. JAMA 264: 2511-2518.
37. Romero J, Lastres-Becker I, de Miguel R, Berrendero F, Ramos JA, Fernandez-Ruiz J, (2002) The endogenous cannabinoid system and the basal ganglia: biochemical, pharmacological, and therapeutic aspects. Pharmacol Ther 95: 137-152. (Pubitemid 35232132)
38. Scavone JL, Mackie K, Van Bockstaele EJ, (2010) Characterization of cannabinoid-1 receptors in the locus coeruleus: relationship with mu-opioid receptors. Brain Res 1312: 18-31.
39. Soria G, Mendizabal V, Tourino C, Ledent C, Parmentier M, Maldonado R, Valverde O, (2005) Lack of CB1 cannabinoid receptor impairs cocaine self-administration. Neuropsychopharmacology 30: 1670-1680. (Pubitemid 43086024)
40. Thanos PK, Dimitrakakis ES, Rice O, Gifford A, Volkow ND, (2005) Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors. Behav Brain Res 164: 206-213. (Pubitemid 41337875)
41. Tian C, Hinds DA, Shigeta R, Kittles R, Ballinger DG, Seldin MF, (2006) A genomewide single-nucleotide-polymorphism panel with high ancestry information for African American admixture mapping. Am J Hum Genet 79: 640-649. (Pubitemid 44452741)
42. Volkow ND, (2002) Involvement of dopamine in drug reinforcement and addiction in human subjects. Eur Neuropsychopharmacol 12: S7-S7.
43. Wang L, Liu H, Harvey-White J, Zimmer A, Kunos G, (2003) Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc Natl Acad Sci USA 100: 1393-1398. (Pubitemid 36184012)
44. Xi ZX, Gilbert JG, Peng XQ, Pak AC, Li X, Gardner EL, (2006) Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens. J Neurosci 26: 8531-8536. (Pubitemid 44316182)
45. Zuo LJ, Kranzler HR, Luo XG, Covault J, Gelernter J, (2007) CNR1 variation modulates risk for drug and alcohol dependence. Biol Psychiatry 62: 616-626. (Pubitemid 47314382)
46. Zuo L, Kranzler HR, Luo X, Yang BZ, Weiss R, Brady K, Poling J, Farrer L, Gelernter J, (2009) Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans: a replication study in family-based sample and population-based sample. Neuropsychopharmacology 34: 1504-1513.